list of glp-1 agonists current and its analogs [36-39] List of approved and pending
Description
The reason for this is because there are limited studies on the pathophysiology in children and animal models that fully recapitulate pediatric MASLD/MASH
![list of glp-1 agonists current and its analogs [36-39] List of approved and pending](http://justmelt.com/cdn/shop/articles/GLP-1-weight-loss-medications-list_600x.jpg?v=1736449746)
The FDA approved sitagliptin, the first DPP-4i on the market, in 2006 and shortly after, numerous additional DPP-4i received market clearance
![list of glp-1 agonists current and its analogs [36-39] List of approved and pending](https://cdn.sanity.io/images/0vv8moc6/ajmc/0e32ba1ee7a476f7e98a6224b123ce23ed410611-6000x2247.jpg)
Concurrently with reductions in glycemia and body weight, retatrutide dose-dependently reduced systolic and diastolic blood pressure and improved lipid profiles, notably reducing non-HDL-C concentrations while decreasing triglyceride by up to 35% (Rosenstock et al
Structure Therapeutics
![list of glp-1 agonists current and its analogs [36-39] List of approved and pending](https://diabetesed.net/wp-content/uploads/2025/09/gLP-cheat-sheet.webp)
Tye, S.T
![list of glp-1 agonists current and its analogs [36-39] List of approved and pending](https://www.rivasweightloss.com/wp-content/uploads/2024/05/glp-1-banner.png)
Sabbagh, M